| Atlantic Knee Restoration & Regenerative Medicine - Alexandria | |
|
1800 N Beauregard St Ste 101 Alexandria VA 22311-1726 | |
| (256) 302-2228 | |
| Not Available |
| Full Name | Atlantic Knee Restoration & Regenerative Medicine - Alexandria |
|---|---|
| Speciality | Physical Medicine & Rehabilitation |
| Location | 1800 N Beauregard St Ste 101, Alexandria, Virginia |
| Authorized Official Name and Position | Robert Crittenden (OWNER) |
| Authorized Official Contact | 2563022228 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Atlantic Knee Restoration & Regenerative Medicine - Alexandria 1800 N Beauregard St Ste 101 Alexandria VA 22311-1726 Ph: (256) 302-2228 | Atlantic Knee Restoration & Regenerative Medicine - Alexandria 1800 N Beauregard St Ste 101 Alexandria VA 22311-1726 Ph: (256) 302-2228 |
| NPI Number | 1598335606 |
|---|---|
| Provider Enumeration Date | 06/30/2021 |
| Last Update Date | 07/07/2022 |
| Medicare PECOS PAC ID | 3274937511 |
|---|---|
| Medicare Enrollment ID | O20210809000994 |
News Archive
New research shows a possible connection between the risk of childhood obesity and maternal consumption of omega-3 fatty acids during pregnancy. Intake of the omega-3s found in seafood is also linked to reduced risk of recurrent breast cancer, stroke in women and early age-related macular degeneration (AMD).
Affecting almost 600,000 people worldwide every year, and with only a 50% survival rate, oral squamous cell carcinoma (OSCC) is one of the more common and deadly forms of cancer.
APR announces the grant of the European CE approval of Nexodyn, a newly developed innovative product intended for use in a variety of wound conditions such as acute wounds, burns and advanced ulcers including venous and pressure ulcers and diabetic foot ulcers.
Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598335606 | NPI | - | NPPES |
| Provider Name | Darlene Lynette Jones |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1184771891 PECOS PAC ID: 0345272621 Enrollment ID: I20140905001657 |
News Archive
New research shows a possible connection between the risk of childhood obesity and maternal consumption of omega-3 fatty acids during pregnancy. Intake of the omega-3s found in seafood is also linked to reduced risk of recurrent breast cancer, stroke in women and early age-related macular degeneration (AMD).
Affecting almost 600,000 people worldwide every year, and with only a 50% survival rate, oral squamous cell carcinoma (OSCC) is one of the more common and deadly forms of cancer.
APR announces the grant of the European CE approval of Nexodyn, a newly developed innovative product intended for use in a variety of wound conditions such as acute wounds, burns and advanced ulcers including venous and pressure ulcers and diabetic foot ulcers.
Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise.
› Verified 2 days ago
| Provider Name | Samantha Lynn Del Riego |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780219527 PECOS PAC ID: 6608296264 Enrollment ID: I20201020002190 |
News Archive
New research shows a possible connection between the risk of childhood obesity and maternal consumption of omega-3 fatty acids during pregnancy. Intake of the omega-3s found in seafood is also linked to reduced risk of recurrent breast cancer, stroke in women and early age-related macular degeneration (AMD).
Affecting almost 600,000 people worldwide every year, and with only a 50% survival rate, oral squamous cell carcinoma (OSCC) is one of the more common and deadly forms of cancer.
APR announces the grant of the European CE approval of Nexodyn, a newly developed innovative product intended for use in a variety of wound conditions such as acute wounds, burns and advanced ulcers including venous and pressure ulcers and diabetic foot ulcers.
Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise.
› Verified 2 days ago
| Provider Name | Nicole Herberger |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811560972 PECOS PAC ID: 4385049121 Enrollment ID: I20210902001645 |
News Archive
New research shows a possible connection between the risk of childhood obesity and maternal consumption of omega-3 fatty acids during pregnancy. Intake of the omega-3s found in seafood is also linked to reduced risk of recurrent breast cancer, stroke in women and early age-related macular degeneration (AMD).
Affecting almost 600,000 people worldwide every year, and with only a 50% survival rate, oral squamous cell carcinoma (OSCC) is one of the more common and deadly forms of cancer.
APR announces the grant of the European CE approval of Nexodyn, a newly developed innovative product intended for use in a variety of wound conditions such as acute wounds, burns and advanced ulcers including venous and pressure ulcers and diabetic foot ulcers.
Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise.
› Verified 2 days ago
| Provider Name | Lauren Alison Kerr |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447916036 PECOS PAC ID: 3274924949 Enrollment ID: I20220107000402 |
News Archive
New research shows a possible connection between the risk of childhood obesity and maternal consumption of omega-3 fatty acids during pregnancy. Intake of the omega-3s found in seafood is also linked to reduced risk of recurrent breast cancer, stroke in women and early age-related macular degeneration (AMD).
Affecting almost 600,000 people worldwide every year, and with only a 50% survival rate, oral squamous cell carcinoma (OSCC) is one of the more common and deadly forms of cancer.
APR announces the grant of the European CE approval of Nexodyn, a newly developed innovative product intended for use in a variety of wound conditions such as acute wounds, burns and advanced ulcers including venous and pressure ulcers and diabetic foot ulcers.
Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise.
› Verified 2 days ago
| Provider Name | Kristi M Phillips |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952641433 PECOS PAC ID: 6709021934 Enrollment ID: I20230502000646 |
News Archive
New research shows a possible connection between the risk of childhood obesity and maternal consumption of omega-3 fatty acids during pregnancy. Intake of the omega-3s found in seafood is also linked to reduced risk of recurrent breast cancer, stroke in women and early age-related macular degeneration (AMD).
Affecting almost 600,000 people worldwide every year, and with only a 50% survival rate, oral squamous cell carcinoma (OSCC) is one of the more common and deadly forms of cancer.
APR announces the grant of the European CE approval of Nexodyn, a newly developed innovative product intended for use in a variety of wound conditions such as acute wounds, burns and advanced ulcers including venous and pressure ulcers and diabetic foot ulcers.
Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise.
› Verified 2 days ago
News Archive
New research shows a possible connection between the risk of childhood obesity and maternal consumption of omega-3 fatty acids during pregnancy. Intake of the omega-3s found in seafood is also linked to reduced risk of recurrent breast cancer, stroke in women and early age-related macular degeneration (AMD).
Affecting almost 600,000 people worldwide every year, and with only a 50% survival rate, oral squamous cell carcinoma (OSCC) is one of the more common and deadly forms of cancer.
APR announces the grant of the European CE approval of Nexodyn, a newly developed innovative product intended for use in a variety of wound conditions such as acute wounds, burns and advanced ulcers including venous and pressure ulcers and diabetic foot ulcers.
Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise.
› Verified 2 days ago
Alexandria Primary Care Associates Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1500 N Beauregard St Ste 110, Alexandria, VA 22311 Phone: 703-370-9002 Fax: 703-370-2849 | |
Franconia Internists, Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5115 Franconia Rd, Alexandria, VA 22310 Phone: 703-660-0026 Fax: 703-922-4253 | |
Bradlee Family Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3541 W Braddock Rd, 101, Alexandria, VA 22302 Phone: 703-379-6020 Fax: 703-820-8799 | |
Rediclinic Of Va, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7100 Silver Lake Blvd, Alexandria, VA 22315 Phone: 713-335-1731 Fax: 713-358-4881 | |
Avicenna Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5100 Leesburg Pike Ste 101, Alexandria, VA 22302 Phone: 703-705-9500 Fax: 703-417-9051 | |
First Step Family Care, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3303 Duke Street, Alexandria, VA 22314 Phone: 703-212-6644 Fax: 703-212-6619 | |
Ahmed Elebiary Md, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 900 Virginia Ave, Alexandria, VA 22302 Phone: 703-705-9500 Fax: 571-685-2016 |